Biomagnetics Diagnostics Corp.

OTC: BMGP · Healthcare · Medical - Specialties

PublicHQ Orangevale, Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 5

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ workforce scale, market scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$518.1k

Employees

Market cap

$1.3k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02012

Net income-$518.1k-$518.1k2012

Operating income-$381.4k-$381.4k2012

Total assets$1.3M$1.3M2012

Liabilities$311.3k$311.3k2012

Equity$976.6k$976.6k2012

Revenue trend

FY2009 – FY2012 · USD

FY09

FY10

FY11

FY12

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Biomagnetics Diagnostics Corp. booked $0 in FY2012 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

FusionPharm, Inc.——PsyBio Therapeutics Corp——Bionik Laboratories Corp.——RavenQuest BioMed Inc.——

Key facts

CEOClayton Hardman

SectorHealthcare

IndustryMedical - Specialties

HeadquartersOrangevale, null

ExchangeOTC: BMGP

Employees2

IPO date2023-07-27

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.